The Potent and Selective Oral STAT6 Degrader, KT-621, Affects Gene Transcripts in Human Keratinocytes As Effectively As Dupilumab, and Blocks Th2 Inflammation in Atopic Dermatitis and Asthma Mouse Models. J of Skin 2025, 9 (6), s629. https://doi.org/10.25251/xbb5zx93.